We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.71B
AUM Growth
+$351M
Cap. Flow
-$22.1M
Cap. Flow %
-0.6%
Top 10 Hldgs %
21.85%
Holding
5,705
New
584
Increased
2,919
Reduced
1,681
Closed
462

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$127M
2
BIL icon
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
+$20M
3
PLTR icon
Palantir
PLTR
+$18.3M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$16.7M
5
DEO icon
Diageo
DEO
+$16.3M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$206M
2
META icon
Meta Platforms (Facebook)
META
+$37.5M
3
AMZN icon
Amazon
AMZN
+$35.5M
4
AVGO icon
Broadcom
AVGO
+$34.8M
5
MSFT icon
Microsoft
MSFT
+$29.8M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 11.61%
3 Healthcare 8.42%
4 Industrials 6.72%
5 Consumer Discretionary 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOLV icon
2276
Solventum
SOLV
$14.4B
$114K ﹤0.01%
1,497
-3,617
-71% -$256K
AMG icon
2277
Affiliated Managers Group
AMG
$9.65B
$113K ﹤0.01%
576
-221
-28% -$38.3K
BHVN icon
2278
Biohaven
BHVN
$2.13B
$113K ﹤0.01%
8,031
+5,341
+199% +$95.2K
DX
2279
Dynex Capital
DX
$3.2B
$113K ﹤0.01%
9,244
-3,365
-27% -$40.8K
NEOG icon
2280
Neogen
NEOG
$2.51B
$113K ﹤0.01%
23,585
+19,220
+440% +$110K
ANIP icon
2281
ANI Pharmaceuticals
ANIP
$1.72B
$113K ﹤0.01%
1,727
+1,458
+542% +$94.9K
PRLB icon
2282
Protolabs
PRLB
$2.17B
$112K ﹤0.01%
2,806
+2,200
+363% +$82K
ALK icon
2283
Alaska Air
ALK
$5.43B
$112K ﹤0.01%
2,270
-4,909
-68% -$239K
FMAO icon
2284
Farmers & Merchants Bancorp
FMAO
$480M
$112K ﹤0.01%
4,436
+4,013
+949% +$96.3K
LADR
2285
Ladder Capital
LADR
$1.26B
$112K ﹤0.01%
10,425
+4,910
+89% +$51.6K
STVN icon
2286
Stevanato
STVN
$5.73B
$112K ﹤0.01%
4,585
+4,250
+1,269% +$96K
OSBC icon
2287
Old Second Bancorp
OSBC
$1.3B
$112K ﹤0.01%
6,306
+5,153
+447% +$84K
MRX
2288
Marex Group Limited Ordinary Shares
MRX
$4.35B
$112K ﹤0.01%
+2,827
New +$118K
CHRW icon
2289
C.H. Robinson
CHRW
$16.9B
$111K ﹤0.01%
1,162
-526
-31% -$49.3K
CRMD icon
2290
CorMedix
CRMD
$570M
$111K ﹤0.01%
9,032
+8,272
+1,088% +$91.3K
CIVB icon
2291
Civista Bancshares
CIVB
$593M
$111K ﹤0.01%
4,795
+4,253
+785% +$92.5K
BRKL
2292
DELISTED
Brookline Bancorp
BRKL
$111K ﹤0.01%
10,526
+6,714
+176% +$69.7K
MDXG icon
2293
MiMedx Group
MDXG
$630M
$111K ﹤0.01%
18,162
+9,761
+116% +$64.9K
HRMY icon
2294
Harmony Biosciences
HRMY
$2.28B
$111K ﹤0.01%
3,511
+2,711
+339% +$87.2K
HOPE icon
2295
Hope Bancorp
HOPE
$1.81B
$111K ﹤0.01%
10,319
+5,852
+131% +$59K
PCRX icon
2296
Pacira BioSciences
PCRX
$968M
$111K ﹤0.01%
4,624
+3,213
+228% +$81K
GERN icon
2297
Geron
GERN
$1.01B
$110K ﹤0.01%
78,317
+66,294
+551% +$94K
ERIE icon
2298
Erie Indemnity
ERIE
$13.4B
$110K ﹤0.01%
318
-33
-9% -$12.2K
MD icon
2299
Pediatrix Medical
MD
$2.14B
$110K ﹤0.01%
7,685
+5,278
+219% +$72.4K
MCRI icon
2300
Monarch Casino & Resort
MCRI
$2.22B
$110K ﹤0.01%
1,275
+524
+70% +$42.3K
90 91
92
93 94

Similar funds

HFCIX
H&F Corporate Investors X San Francisco, California $3.85B AUM
DWM
Destination Wealth Management Walnut Creek, California $3.85B AUM 13% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
AC
Anther Capital Hong Kong $3.83B AUM
IP
Interval Partners New York $3.82B AUM 27.38% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Tower Research Capital (TRC) held 5,705 positions worth $3.71B, up 10% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC)'s Q2 2025 filing shows 584 new, 2,919 increased, 1,681 reduced and 462 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M. The largest sale was Invesco QQQ Trust, an estimated $206M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Tower Research Capital (TRC)'s largest Q2 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $127M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $206M.
  • Tower Research Capital (TRC) fully exited iShares S&P 500 Value ETF in Q2 2025, selling an estimated $6.43M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.71B portfolio in Q2 2025.
  • Tower Research Capital (TRC) opened 584 new positions and closed 462 in Q2 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 10% quarter-over-quarter to $3.71B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.